{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:19:20Z","timestamp":1787833160019,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.therap.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:46:42Z","timestamp":1785426402000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of patients with opioid\/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study"],"prefix":"10.1016","author":[{"given":"Ismahane","family":"Merah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"de Ternay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjesa","family":"Veseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafae","family":"Chinoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Ragonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montassar","family":"Taj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Salihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Chappuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-3635","authenticated-orcid":false,"given":"Benjamin","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2026.07.004_bib0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.therap.2026.07.004_bib0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.therap.2026.07.004_bib0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2026.07.004_bib0175","unstructured":"Agence nationale du m\u00e9dicaments et des produits de sant\u00e9 (ANSM). \u00c9tat des lieux de la consummation des benzodiaz\u00e9pines [Inventory of benzodiazepine use in France]. 2017. https:\/\/archive.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Etat-des-lieux-de-la-consommation-des-benzodiazepines-Point-d-Information [Accessed 20 July 2026]."},{"key":"10.1016\/j.therap.2026.07.004_bib0180","doi-asserted-by":"crossref","first-page":"639780","DOI":"10.3389\/fpsyt.2021.639780","article-title":"Gabapentinoid abuse in France: Evidence on health consequences and new points of vigilance","volume":"12","author":"Tambon","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.therap.2026.07.004_bib0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/fcp.12612","article-title":"Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France","volume":"35","author":"Soeiro","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2026.07.004_bib0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.therap.2021.01.058","article-title":"Thirty years of nefopam abuse in France","volume":"76","author":"Revol","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.07.004_bib0195","first-page":"24","article-title":"Le Centre ressource lyonnais des addictions m\u00e9dicamenteuses (CERLAM)","volume":"26","author":"Chappuy","year":"2024","journal-title":"Courr Addict"},{"key":"10.1016\/j.therap.2026.07.004_bib0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2026.07.004_bib0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.therap.2026.07.004_bib0210","unstructured":"World Health Organization. The World Health Organization quality of life (WHOQOL)-BREF. Revision 2012. https:\/\/iris.who.int\/handle\/10665\/77773 [Accessed 20 July 2026]."},{"key":"10.1016\/j.therap.2026.07.004_bib0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.therap.2026.07.004_bib0220","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"key":"10.1016\/j.therap.2026.07.004_bib0225","unstructured":"Haute Autorit\u00e9 de sant\u00e9. \u00c9chelle cognitive d\u2019attachement aux benzodiaz\u00e9pines. 2007. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/arret_des_bzd_-_echelle_ecab.pdf [Accessed 20 July 2026]."},{"key":"10.1016\/j.therap.2026.07.004_bib0230","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s12630-022-02210-7","article-title":"Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F)","volume":"69","author":"Delage","year":"2022","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.therap.2026.07.004_bib0235","doi-asserted-by":"crossref","first-page":"108978","DOI":"10.1016\/j.drugalcdep.2021.108978","article-title":"Gender differences in the prevalence of heroin and opioid analgesic misuse in the United States, 2015-2019","volume":"227","author":"McHugh","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2026.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1604755","DOI":"10.3389\/ijph.2022.1604755","article-title":"Nationwide population-based study about patterns of prescription opioid use and misuse among young adults in Spain","volume":"67","author":"Carrasco-Garrido","year":"2022","journal-title":"Int J Public Health"},{"key":"10.1016\/j.therap.2026.07.004_bib0245","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1038\/s41598-024-63037-4","article-title":"Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study","volume":"14","author":"Thomas","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.therap.2026.07.004_bib0250","doi-asserted-by":"crossref","first-page":"17m11958","DOI":"10.4088\/JCP.17m11958","article-title":"Sources of prescription medication misuse among young adults in the United States: The role of educational status","volume":"79","author":"McCabe","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.therap.2026.07.004_bib0255","doi-asserted-by":"crossref","first-page":"112530","DOI":"10.1016\/j.drugalcdep.2024.112530","article-title":"Pain severity contributes to worse outcomes in opioid use disorder recovery than pain status","volume":"267","author":"Craft","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2026.07.004_bib0260","first-page":"260","article-title":"Benzodiazepine use disorder: Common questions and answers","volume":"108","author":"Robertson","year":"2023","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.therap.2026.07.004_bib0265","doi-asserted-by":"crossref","first-page":"107507","DOI":"10.1016\/j.addbeh.2022.107507","article-title":"Associations between insomnia symptoms and prescription opioid and benzodiazepine misuse in a nationally representative sample","volume":"137","author":"Short","year":"2023","journal-title":"Addict Behav"},{"key":"10.1016\/j.therap.2026.07.004_bib0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijerph14010038","article-title":"Determinants of quality of life in high-dose benzodiazepine misusers","volume":"14","author":"Tamburin","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.therap.2026.07.004_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13722-023-00397-8","article-title":"Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study","volume":"18","author":"Meyer","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.therap.2026.07.004_bib0280","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12889-019-6933-8","article-title":"Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort","volume":"19","author":"Airagnes","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.therap.2026.07.004_bib0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psychres.2017.01.046","article-title":"Socio-demographic factors and long-term use of benzodiazepines in patients with depression, anxiety or insomnia","volume":"249","author":"Sj\u00f6stedt","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.therap.2026.07.004_bib0290","doi-asserted-by":"crossref","first-page":"18m12174","DOI":"10.4088\/JCP.18m12174","article-title":"Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States","volume":"79","author":"Blanco","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.therap.2026.07.004_bib0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.genhosppsych.2023.09.002","article-title":"Race, economic status, and disparities in the receipt of benzodiazepine prescriptions in a large primary care sample","volume":"85","author":"Dore","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.therap.2026.07.004_bib0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/02791072.2023.2191610","article-title":"An Analysis of benzodiazepine prescribing to primary care patients in a large healthcare system from 2019-2020","volume":"56","author":"Weleff","year":"2024","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.therap.2026.07.004_bib0305","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101014","article-title":"Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review","volume":"4","author":"Gentile","year":"2020","journal-title":"BJGP Open"},{"key":"10.1016\/j.therap.2026.07.004_bib0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/wps.21191","article-title":"The value and limitations of self-administered questionnaires in clinical practice and epidemiological studies","volume":"23","author":"Zimmerman","year":"2024","journal-title":"World Psychiatry"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572600079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572600079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:36:37Z","timestamp":1787830597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059572600079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S004059572600079X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2026.07.004","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of patients with opioid\/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}